If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Director/PDMR Shareholding

26 Jan 2017 10:10

RNS Number : 2106V
Scapa Group PLC
26 January 2017
 

26 January 2017

SCAPA GROUP PLC

('the Company')

Director/PDMR Notification

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Scapa Group plc (AIM: SCPA), a global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets, was notified on 25 January 2017 that James Archibald Simpson Wallace, Group Chairman of the Company, sold 150,000 ordinary shares of 5 pence each in the share capital of the Company ('Ordinary Shares') at a price of 320 pence per Ordinary Share and 250,000 ordinary shares of 5 pence each in the share capital of the Company ('Ordinary Shares') at a price of 321 pence per Ordinary Share on 25 January 2017, as detailed below.

On 15 December 2016, Mr Wallace announced his retirement as Chairman of the Board of Scapa Group plc with effect from 31 March 2017, at which point Mr Larry Pentz will assume Chairmanship.

Following the sale Mr. Wallace holds 70,000 Shares in the Company.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Archibald Simpson Wallace

 

2

Reason for the notification

a)

Position / status

Group Chairman

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of financial instrument,

type of instrument

 

Ordinary shares of 5p each

Identification Code

GB0007281198

b)

Nature of the transaction

Sale of shares

 

c)

Price(s) and volume(s)

 

Sale of 150,000 shares at 320p per share

Sale of 250,000 shares at 321p per share

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

25 January 2017

f)

Place of the transaction

London

 

For further information please contact:-

 

Graham Hardcastle Group Finance Director/Company Secretary

Scapa Group plc

Tel: 0161 301 7400

 

Richard Thomas Numis Securities Limited

Nominated Adviser and Joint Broker

Tel: 0207 260 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUNRRRBKAAUAR
Date   Source Headline
1st Dec 201510:11 amRNSHolding(s) in Company
1st Dec 201510:10 amRNSHolding(s) in Company
30th Nov 201510:34 amRNSTotal Voting Rights
24th Nov 20157:00 amRNSInterim Results
3rd Nov 20154:55 pmRNSHolding(s) in Company
3rd Nov 20154:54 pmRNSShareholder Circular Posted
13th Oct 20157:00 amRNSTrading Statement
10th Sep 20151:03 pmRNSAdditional Listing
9th Sep 20159:48 amRNSHolding(s) in Company
1st Sep 20153:57 pmRNSBlocklisting Interim Review
1st Sep 20153:29 pmRNSAdditional Listing
11th Aug 20151:28 pmRNSAdditional Listing
10th Aug 20159:46 amRNSDirector/PDMR Shareholding
23rd Jul 20159:21 amRNSDirector/PDMR Shareholding
21st Jul 20157:00 amRNSAGM Statement
14th Jul 20153:56 pmRNSAdditional Listing
13th Jul 20151:26 pmRNSHolding(s) in Company
2nd Jul 201511:15 amRNSAdditional Listing
17th Jun 20157:00 amRNSHealthcare Site Visit
16th Jun 20159:15 amRNSAdditional Listing
10th Jun 20152:54 pmRNSHolding(s) in Company
5th Jun 20159:01 amRNSHolding(s) in Company
4th Jun 20159:31 amRNSHolding(s) in Company
3rd Jun 20158:59 amRNSHolding(s) in Company
27th May 20157:00 amRNSFinal Results
28th Apr 20153:27 pmRNSAdditional Listing
9th Apr 20157:00 amRNSTrading Statement
7th Apr 20154:38 pmRNSHolding(s) in Company
7th Apr 20153:43 pmRNSAdditional Listing
31st Mar 20159:12 amRNSTotal Voting Rights
30th Mar 20154:02 pmRNSAdditional Listing
30th Mar 20152:58 pmRNSDirector/PDMR Shareholding
18th Mar 20154:45 pmRNSHolding(s) in Company
16th Mar 20154:20 pmRNSAdditional Listing
10th Mar 20154:10 pmRNSAdditional Listing
9th Mar 20157:00 amRNSHolding(s) in Company
5th Mar 20157:00 amRNSDirector/PDMR Shareholding
5th Mar 20157:00 amRNSDirector/PDMR Shareholding
4th Mar 20157:00 amRNSDirector/PDMR Shareholding
2nd Mar 20153:58 pmRNSAdditional Listing
2nd Mar 20157:00 amRNSAcquisition
23rd Feb 20159:08 amRNSHolding(s) in Company
16th Feb 20159:01 amRNSHolding(s) in Company
13th Feb 20159:09 amRNSHolding(s) in Company
11th Feb 201510:52 amRNSHolding(s) in Company
9th Feb 20151:35 pmRNSHolding(s) in Company
9th Feb 201510:33 amRNSBlocklisting Interim Review
4th Feb 201512:18 pmRNSHolding(s) in Company
23rd Jan 20159:59 amRNSHolding(s) in Company
31st Dec 201412:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.